Aeolus Pharmaceuticals, Inc. AOLS Company Overview Stock

New Post Public Reply Private Reply Replies (0) Message Board

Sep 7, 2013 at 3:53 PM

Aeolus Pharmaceuticals, Inc. AOLS Company Overview

Stock Message Board http://investorshangout.com/search?q=AOLS&...mp;yt1=Go!

Aeolus Pharmaceuticals, Inc. AOLS Current Price and Quotes
Last Price 0.2494
Previous Close 0.22 Open 0.2494
Daily Range 0.2494 - 0.2494 52wk Range 0.475 - 0.22
Volume 350 Dividend N/A
Average Vol (3m) 38,878 Yield N/A
Aeolus Pharmaceuticals, Inc. AOLS
Company Information

26361 Crown Valley Parkway
Suite 150
Mission Viejo, CA 92691

Website: http://www.aeoluspharma.com
Phone: 949-481-9825

Aeolus Pharmaceuticals, Inc. AOLS
Aeolus Pharmaceuticals, Inc. AOLS
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0001261734
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

David Cavalier Interim CFO
John L. McManus President, CEO
Company Directors

David Cavalier Chairman
Company Notes

Formerly=Incara Pharmaceuticals Corp. until 7-04
Formerly=Intercardia, Inc. until 7-99
Service Providers

Auditor/Accountant
Grant Thornton LLP
226 Causeway Street
Boston, MA, 02114
United States

Legal Counsel
Not Available
Investor Relations Firm
Not Available

Aeolus Pharmaceuticals, Inc. AOLS
AOLS Security Details

Share Structure

Market Value1 $33,556,787 a/o Sep 06, 2013
Shares Outstanding 134,550,068 a/o Aug 04, 2013
Float Not Available
Authorized Shares Not Available
Par Value 0.001
Shareholders

Shareholders of Record 93 a/o Dec 31, 2012
Security Notes

Issued=11-03 pursuant to reorganization by merger of company into one of its wholly-owned subsidiaries. Company's common stock converted into common stock of the merged company, which will continue to trade under the old company's name & stock symbol
Capital Change=shs decreased by 1 for 10 split. Pay date=07/16/2004.
Short Selling Data

Short Interest 100 (-99.42%)
Aug 15, 2013
Significant Failures to Deliver No
Transfer Agent(s)

American Stock Transfer & Trust Company

Aeolus Pharmaceuticals, Inc. AOLS Recent News

Aug 15, 2013 Aeolus Announces Third Quarter Fiscal Year 2013 Financial Results
Jul 2, 2013 Aeolus' AEOL 10150 Significantly Improves Survival From Nitrogen Mustard Exposure to Skin in Animals
Jun 26, 2013 Aeolus' AEOL 10150 Significantly Improves Survival in Animals Exposed to Mustard Gas

Aeolus Pharmaceuticals, Inc. AOLS Financials
Period Ending Sep 30, 2012 Sep 30, 2011 Sep 30, 2010 Sep 30, 2009
Total Revenue 7,293 4,821 - -
Cost of Revenue - - - -
Gross Profit 7,293 4,821 - -
Operating Expenses

Research and Development 6,468 5,055 1,690 711
Sales, General and Admin. 3,196 3,668 1,954 1,292
Non-Recurring Items - - - -
Other - - - -
Operating Income (2,371) (3,902) (3,644) (2,003)
Income From Continuing Operations

Add'l Income/Expense Items 4,069 4,222 (21,347) 148
Earnings Before Interest and Tax 1,698 320 (24,991) (1,855)
Interest Expense - 21 878 441
Earnings Before Tax 1,698 299 (25,869) (2,296)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 1,698 299 (25,869) (2,296)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 1,698 299 (25,869) (2,296)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 1,698 299 (25,869) (2,296)

AOLS Aeolus Pharmaceuticals, Inc. Research DD Guide

AOLS Aeolus Pharmaceuticals, Inc. Stock Message Board http://investorshangout.com/search?q=AOLS&...mp;yt0=Go!
AOLS Aeolus Pharmaceuticals, Inc. Stock Quote http://www.otcmarkets.com/stock/AOLS/quote
AOLS Aeolus Pharmaceuticals, Inc. Stock Chart http://www.otcmarkets.com/stock/AOLS/chart
AOLS Aeolus Pharmaceuticals, Inc. Company Info http://www.otcmarkets.com/stock/AOLS/company-info
AOLS Aeolus Pharmaceuticals, Inc. Recent News http://www.otcmarkets.com/stock/AOLS/news
AOLS Aeolus Pharmaceuticals, Inc. Financials http://www.otcmarkets.com/stock/AOLS/financials
AOLS Aeolus Pharmaceuticals, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/AOLS/filings
AOLS Aeolus Pharmaceuticals, Inc. Short Sales http://www.otcmarkets.com/stock/AOLS/short-sales
AOLS Aeolus Pharmaceuticals, Inc. Insider Disclosure http://www.otcmarkets.com/stock/AOLS/insider-transactions
AOLS Aeolus Pharmaceuticals, Inc. Research Reports http://www.otcmarkets.com/stock/AOLS/research
AOLS Aeolus Pharmaceuticals, Inc. Summary http://finance.yahoo.com/q?s=AOLS
AOLS Aeolus Pharmaceuticals, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=AOLS+Historical+Prices
AOLS Aeolus Pharmaceuticals, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=AOLS
AOLS Aeolus Pharmaceuticals, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=AOLS+Basic+Chart
AOLS Aeolus Pharmaceuticals, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=AOLS+Basic+Tech.+Analysis
AOLS Aeolus Pharmaceuticals, Inc. Headlines http://finance.yahoo.com/q/h?s=AOLS+Headlines
AOLS Aeolus Pharmaceuticals, Inc. Press Releases http://finance.yahoo.com/q/p?s=AOLS+Press+Releases
AOLS Aeolus Pharmaceuticals, Inc. Company Profile http://finance.yahoo.com/q/pr?s=AOLS+Profile
AOLS Aeolus Pharmaceuticals, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=AOLS+Key+Statistics
AOLS Aeolus Pharmaceuticals, Inc. Industry http://finance.yahoo.com/q/in?s=AOLS+Industry
AOLS Aeolus Pharmaceuticals, Inc. Major Holders http://finance.yahoo.com/q/mh?s=AOLS+Major+Holders
AOLS Aeolus Pharmaceuticals, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=AOLS+Insider+Transactions
AOLS Aeolus Pharmaceuticals, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=AOLS+Insider+Roster
AOLS Aeolus Pharmaceuticals, Inc. Income Statement http://finance.yahoo.com/q/is?s=AOLS
AOLS Aeolus Pharmaceuticals, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=AOLS
AOLS Aeolus Pharmaceuticals, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=AOLS+Cash+Flow&annual
AOLS Aeolus Pharmaceuticals, Inc. Nasdaq http://www.nasdaq.com/symbol/AOLS
AOLS Aeolus Pharmaceuticals, Inc. Market Watch http://www.marketwatch.com/investing/stock/AOLS
AOLS Aeolus Pharmaceuticals, Inc. Bloomberg http://www.bloomberg.com/quote/AOLS:US
AOLS Aeolus Pharmaceuticals, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=AOLS
AOLS Aeolus Pharmaceuticals, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=AOLS
AOLS Aeolus Pharmaceuticals, Inc. Barchart http://www.barchart.com/quotes/stocks/AOLS
AOLS Aeolus Pharmaceuticals, Inc. OTC Short Report http://otcshortreport.com/index.php?index=AOLS
AOLS Aeolus Pharmaceuticals, Inc. Investopedia http://www.investopedia.com/markets/stocks/AOLS/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...